Dergiler / Düzce Tıp Fakültesi Dergisi / 2026 / Volume: 28 Issue: 2

Ketofol vs Propofol Sedation in Advanced Endoscopic Procedures: Impact on Hypoxemia and Airway Intervention

Sayfa
—
Yayın Tarihi
2026-08-21
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These findings suggest that ketofol may offer a potential respiratory safety advantage, although prospective randomized studies are needed to confirm this association.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Advanced endoscopic procedures such as endoscopic ultrasonography (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) require deep sedation, during which respiratory complications remain a major concern.
📊
Temel Bulgular & Veri:Material and Methods: This retrospective, single-center observational study included 125 adult participants who underwent EUS or ERCP and received either propofol (n=63) or ketofol (n=62) sedation.
💡
Sonuç & Katkı:These findings suggest that ketofol may offer a potential respiratory safety advantage, although prospective randomized studies are needed to confirm this association.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Ketofol · propofol · hypoxemia

Abstract

Aim: Advanced endoscopic procedures such as endoscopic ultrasonography (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) require deep sedation, during which respiratory complications remain a major concern. This study aimed to compare the effects of propofol and a ketamine–propofol combination (ketofol) on hypoxemia and airway intervention. Material and Methods: This retrospective, single-center observational study included 125 adult participants who underwent EUS or ERCP and received either propofol (n=63) or ketofol (n=62) sedation. The primary outcome was hypoxemia, defined as peripheral oxygen saturation (SpO₂) <90% sustained for at least 10 seconds, and the secondary outcome was the requirement for an airway intervention. Clinical, procedural, and sedation-related variables were analyzed. Results: Hypoxemia occurred in 18 (28.6%) participants in the propofol group and 9 (14.5%) participants in the ketofol group (p=0.056). The lowest recorded SpO₂ was lower in the propofol group than in the ketofol group (91.2±4.8% vs 93.6±3.9%, p=0.003). Airway intervention was required in 14 (22.2%) and 6 (9.7%) participants, respectively (p=0.056). Ketofol sedation was independently associated with a lower risk of hypoxemia (adjusted odds ratio: 0.42, 95% confidence interval: 0.18-0.98, p=0.044). Older age, higher body mass index, American Society of Anesthesiologists physical status class III-IV, and longer procedure duration were independently associated with an increased risk of hypoxemia. Conclusion: Ketofol sedation was independently associated with a lower risk of hypoxemia than propofol alone in patients undergoing advanced endoscopic procedures. These findings suggest that ketofol may offer a potential respiratory safety advantage, although prospective randomized studies are needed to confirm this association.

🔖

Bu Makaleye Atıf Yap

Eşbah, A. Ü., Torun, S. (2026). Ketofol vs Propofol Sedation in Advanced Endoscopic Procedures: Impact on Hypoxemia and Airway Intervention. Düzce Tıp Fakültesi Dergisi, Volume: 28 Issue: 2. https://doi.org/10.18678/dtfd.1940319

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (25)

  1. Caletti G, Fusaroli P. Endoscopic ultrasonography. Endoscopy. 1999;31(1):95-102. doi:10.1055/s-1999-13654.
  2. Canakis A, Tugarinov N, Deliwala S, Twery B, Miro-Gonzalez Á, Beran A, et al. Clinical outcomes of endoscopic ultrasound--guided gallbladder drainage in patients with acute cholecystitis with ≥1 year of follow-up: a systematic review and meta-analysis. Gastrointest Endosc. 2026;103(1):48-56.e11. doi:10.1016/j.gie.2025.07.025.
  3. Barakat M, Saumoy M, Forbes N, Elmunzer BJ. Complications of endoscopic retrograde cholangiopancreatography. Gastroenterology. 2025;169(2):230-43.e8. doi:10.1053/j.gastro.2025.03.009.
  4. Arvanitakis M, Devière J. Endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy. 2009;41(10):890-4. doi:10.1055/s-0029-1215088.
  5. Zhang W, Wang L, Zhu N, Wu W, Liu H. A prospective, randomized, single-blinded study comparing the efficacy and safety of dexmedetomidine and propofol for sedation during endoscopic retrograde cholangiopancreatography. BMC Anesthesiol. 2024;24(1):191. doi:10.1186/s12871-024-02572-z.
  6. Soliman AM, Hamad YM, Almaghraby AA, Mohamed AA, Abdallah SR. Propofol versus dexmedetomidine for sedation of cancer patients undergoing endoscopic retrograde cholangiopancreatography: randomized single-blinded controlled study. Anesth Pain Med. 2024;14(4):e148512. doi:10.5812/aapm-148512.
  7. Lin OS. Sedation for routine gastrointestinal endoscopic procedures: a review on efficacy, safety, efficiency, cost and satisfaction. Intest Res. 2017;15(4):456-66. doi:10.5217/ir.2017.15.4.456.
  8. Amornyotin S. Sedation and monitoring for gastrointestinal endoscopy. World J Gastrointest Endosc. 2013;5(2):47-55. doi:10.4253/wjge.v5.i2.47.
  9. Li J, Liu Y, Chen S, Dai X, Wang J. Pharmacological agents for procedural sedation and analgesia in patients undergoing gastrointestinal endoscopy: a systematic review and network meta-analysis. EClinicalMedicine. 2025;85:103307. doi:10.1016/j.eclinm.2025.103307.
  10. van Beek EJAH, Leroy PL. Safe and effective procedural sedation for gastrointestinal endoscopy in children. J Pediatric Gastroenterol Nutr. 2012;54(2):171-85. doi:10.1097/MPG.0b013e31823a2985.
  11. Sidhu R, Turnbull D, Haboubi H, Leeds JS. British Society of Gastroenterology guidelines on sedation in gastrointestinal endoscopy. Gut. 2024;73(2):219-45. doi:10.1136/gutjnl-2023-330396.
  12. Vila JJ, Kutz M, Goñi S, Ostiz M, Amorena E, Prieto C, et al. Endoscopic and anesthetic feasibility of EUS and ERCP combined in a single session versus two different sessions. World J Gastrointest Endosc. 2011;3(3):57-61. doi:10.4253/wjge.v3.i3.57.
  13. Huang X, Li X, Sun Y, Wu A, Ai P. Comparison of Esketamine/propofol and sufentanil/propofol on intraoperative hypoxemia during bronchoscopy: a randomized trial. Drug Des Devel Ther. 2025;19:4429-36. doi:10.2147/DDDT.S490423.
  14. Fang Y, Xu Y, Cao S, Sun X, Zhang H, Jing Q, et al. Incidence and risk factors for hypoxia in deep sedation of propofol for artificial abortion patients. Front Med. 2022;9:763275. doi:10.3389/fmed.2022.763275.
  15. Xue H, Wei P, Wen Y, He S, Yuan L, Song W. Low-dose esketamine combined with propofol versus fentanyl-propofol for preventing hypoxemia during gastroscopy sedation in high-altitude residents: a randomized controlled trial. BMC Anesthesiol. 2025;25(1):383. doi:10.1186/s12871-025-03280-y.
  16. Schraag S, Pradelli L, Alsaleh AJO, Bellone M, Ghetti G, Chung TL, et al. Propofol vs. inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis. BMC Anesthesiol. 2018;18(1):162. doi:10.1186/s12871-018-0632-3.
  17. Pigò F, Gottin M, Conigliaro R. The incidence of adverse events in adults undergoing procedural sedation with propofol administered by non-anesthetists: a systematic review and meta-analysis. Diagnostics. 2025;15(10):1234. doi:10.3390/diagnostics15101234.
  18. Tellor Pennington BR, Janda AM, Colquhoun DA, Neuman MD, Kidwell KM, Spino C, et al. Trajectories of Recovery after Intravenous propofol versus inhaled VolatilE anaesthesia (THRIVE) randomised controlled trial in the USA: a protocol. BMJ Open. 2025;15(9):e103836. doi:10.1136/bmjopen-2025-103836.
  19. Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018;12(9):755-67. doi:10.1080/17476348.2018.1506331.
  20. Zysman M, Deslee G, Perez T, Burgel PR, Le Rouzic O, Brinchault-Rabin G, et al. Burden and characteristics of severe chronic hypoxemia in a real-world cohort of subjects with COPD. Int J Chron Obstruct Pulmon Dis. 2021;16:1275-84. doi:10.2147/COPD.S295381.
  21. Arora S. Combining ketamine and propofol ("ketofol") for emergency department procedural sedation and analgesia: a review. West J Emerg Med. 2008;9(1):20-3.
  22. Smischney NJ, Hoskote SS, Gallo de Moraes A, Racedo Africano CJ, Carrera PM, Tedja R, et al. Ketamine/propofol admixture (ketofol) at induction in the critically ill against etomidate (KEEP PACE trial): study protocol for a randomized controlled trial. Trials. 2015;16:177. doi:10.1186/s13063-015-0687-0.
  23. Atalay YO, Köksal E, Kaya C, Uzunkaya F, Tomak L. Retrospective evaluation of ketamine-propofol combination for procedural sedation in children undergoing biopsies. Medeniyet Medical Journal. 2016;31(2):77-81.
  24. Choi EJ, Kim CH, Yoon JY, Kim EJ. Ketamine-propofol (ketofol) in procedural sedation: a narrative review. Dent Anesth Pain Med. 2023;23(3):123-33. doi:10.17245/jdapm.2023.23.3.123.
  25. Ghojazadeh M, Sanaie S, Paknezhad SP, Faghih SS, Soleimanpour H. Using ketamine and propofol for procedural sedation of adults in the emergency department: a systematic review and meta-analysis. Adv Pharm Bull. 2019;9(1):5-11. doi:10.15171/apb.2019.002.